VENTRIPACE MEDICAL LTD

12373820
Active United Kingdom

Manufacture of medical and dental instruments and supplies

4 employees website.com
Life sciences and medical technology Manufacture of medical and dental instruments and supplies
V

VENTRIPACE MEDICAL LTD

12373820

Manufacture of medical and dental instruments and supplies

Founded 20 Dec 2019 Active United Kingdom 4 employees website.com
Life sciences and medical technology Manufacture of medical and dental instruments and supplies

Previous Company Names

CARDIAC-TECH LTD 20 Dec 2019 — 8 May 2025
Accounts Submitted 19 Sept 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 9 Jun 2026 Next due 16 May 2027 10 months remaining
Net assets £105K £92K 2024 year on year
Total assets £108K £92K 2024 year on year
Total Liabilities £3K £41 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Website

www.example.com

Full company profile for VENTRIPACE MEDICAL LTD (12373820), an active life sciences and medical technology company based in United Kingdom. Incorporated 20 Dec 2019. Manufacture of medical and dental instruments and supplies. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type total-exemption-full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2020–2024)

Cash in Bank

£19.92k

Decreased by £28.97k (-59%)

Net Assets

£104.59k

Decreased by £92.25k (-47%)

Total Liabilities

£3.42k

Increased by £41.00 (+1%)

Turnover

N/A

Employees

4

Increased by 2 (+100%)

Debt Ratio

3%

Increased by 1 (+50%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

3 Allotments 399,452 Shares £37k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
23 Oct 2025240,000£36k£0.15
22 Mar 2022159,220£1.592£0
22 Apr 2020232£538.24£2.32

Officers

Officers

3 active
Status
Kilcoyne, JohnDirectorAmericanUnited States6615 Aug 2025Active
Meese, Daniel DavidDirectorBritishEngland4620 Dec 2019Active
Stern, Robert AllenDirectorAmerican,germanUnited States6918 Apr 2023Active

Shareholders

Shareholders (4)

Daniel David Meese
46.5%
Brian Thompson
22.3%

Persons with Significant Control

Persons with Significant Control (2)

2 Active 1 Ceased

Daniel David Meese

British

Active
Notified 20 Dec 2019
Residence England
DOB March 1980
Nature of Control
  • Ownership Of Shares 50 To 75 Percent,voting Rights 50 To 75 Percent,right To Appoint And Remove Directors

Mr Daniel David Meese

British

Active
Notified 20 Dec 2019
Residence England
DOB March 1980
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent
  • Right To Appoint And Remove Directors

William Howden Simpson

Ceased 6 May 2020

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
9 Jun 2026Confirmation StatementConfirmation statement made on 2 May 2026 with updates
3 Jun 2026OfficersAppointment of Mr Robert Allen Stern as director
3 Jun 2026OfficersAppointment of Mr John Kilcoyne as director
29 Oct 2025ResolutionResolutions
27 Oct 2025CapitalAllotment of shares (GBP 20.3122) on 23 Oct 2025
9 Jun 2026 Confirmation Statement

Confirmation statement made on 2 May 2026 with updates

3 Jun 2026 Officers

Appointment of Mr Robert Allen Stern as director

3 Jun 2026 Officers

Appointment of Mr John Kilcoyne as director

29 Oct 2025 Resolution

Resolutions

27 Oct 2025 Capital

Allotment of shares (GBP 20.3122) on 23 Oct 2025

Recent Activity

Latest Activity

Confirmation statement made on 2 May 2026 with updates

1 weeks ago on 9 Jun 2026

Appointment of Mr Robert Allen Stern as director

2 weeks ago on 3 Jun 2026

Appointment of Mr John Kilcoyne as director

2 weeks ago on 3 Jun 2026

Resolutions

7 months ago on 29 Oct 2025

Allotment of shares (GBP 20.3122) on 23 Oct 2025

7 months ago on 27 Oct 2025